Korean J Intern Med Search

  • HOME
  • Browse Articles
  • Korean J Intern Med Search
Hemato-oncology
Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
Korean J Intern Med. 2023;38(6):893-902.   Published online August 21, 2023
Full Text     PubReader     ePub     PDF
Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
Korean J Intern Med. 2021;36(Suppl 1):S196-S206.   Published online April 3, 2020
Full Text     PubReader     ePub     PDF
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma
Korean J Intern Med. 2021;36(6):1459-1470.   Published online October 21, 2021
Full Text     PubReader     ePub     PDF     Supplementary
The role of platelet function analyzer-200 in predicting perioperative bleeding risk
Korean J Intern Med. 2020;35(5):1199-1209.   Published online February 6, 2020
Full Text     PubReader     ePub     PDF
Immature platelet fraction based diagnostic predictive scoring model for immune thrombocytopenia
Korean J Intern Med. 2020;35(4):970-978.   Published online April 10, 2020
Full Text     PubReader     ePub     PDF
Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
Korean J Intern Med. 2020;35(1):171-184.   Published online October 26, 2018
Full Text     PubReader     ePub     PDF
Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
Korean J Intern Med. 2019;34(6):1333-1346.   Published online October 26, 2018
Full Text     PubReader     ePub     PDF
Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
Korean J Intern Med. 2018;33(3):642-644.   Published online June 28, 2017
Full Text     PubReader     ePub     PDF
Hemato-oncology
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
Korean J Intern Med. 2017;32(4):711-721.   Published online November 4, 2016
Full Text     PubReader     ePub     PDF
Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
Korean J Intern Med. 2016;31(2):357-366.   Published online February 15, 2016
Full Text     PubReader     ePub     PDF
Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Received June 19, 2023  Accepted November 27, 2023  Published online January 30, 2024
DOI: https://doi.org/10.3904/kjim.2023.265    [Epub ahead of print]
Full Text     PubReader     ePub     PDF     Supplementary

Korean Journal of
Internal Medicine

Print ISSN: 1226-3303
Online ISSN: 2005-6648


Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by Korean Association of Internal Medicine.

Close layer
prev next